82% ofpatientsreportedsneezing(Tyrvaya)Ocularburning17%(Restasis)30 daysupply is 60.2ml vials(Xiidra)Improvementin cornealstaining afterjust 14 days(Cequa)MoneyBackGuarantee(Vevye)SymptomImprovementin the first 30days(Vevye).03mg ofvarenicline(Tyrvaya)one monthsupply is 60.25ml vials(Cequa)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)Throatirritation13% ofpatients(Tyrvaya).09%Cyclosporine(Cequa)Patients stayon treatmentlonger thenRestasis andXiidra(Cequa)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)30-daysupply is two4.2ml bottles(Tyrvaya)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)Improvementin visualacuity as earlyas day 56(Cequa)QID(Miebo)1-3% of pts.reportedblurred visionand eyeredness(Miebo)Lifitegrast5%(Xiidra)Improvementin SchirmerScore at day28(Tyrvaya)Wait 30minutes toinstill contactlenses(Miebo)Installationsitereactions 8%(Vevye)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!Blurred Visionwas the mostcommon ocularadversereaction(Miebo)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air65% of centralcorneas werecompletelyclear at 3months(Cequa)95% of patientsexperienced noor mildinstallation sitepain (Cequa)Availablefor $79(Vevye)The first andonly prescriptiondrop that directlytargets tearevaporation.05%Cyclosporine(Restasis).1%cyclosporine(Vevye)Relief frominflammationin the first 15days(Vevye)100%perfluorohexy-loctane(Miebo)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)2ml in a5ml bottle(Vevye)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)82% ofpatientsreportedsneezing(Tyrvaya)Ocularburning17%(Restasis)30 daysupply is 60.2ml vials(Xiidra)Improvementin cornealstaining afterjust 14 days(Cequa)MoneyBackGuarantee(Vevye)SymptomImprovementin the first 30days(Vevye).03mg ofvarenicline(Tyrvaya)one monthsupply is 60.25ml vials(Cequa)SymptomaticRelief in 2weeks in 2 outof 4 studies(Xiidra)Throatirritation13% ofpatients(Tyrvaya).09%Cyclosporine(Cequa)Patients stayon treatmentlonger thenRestasis andXiidra(Cequa)Increase inSchirmer scoreof 10mm overvehicle in 6 mo(Restasis)30-daysupply is two4.2ml bottles(Tyrvaya)Indicated forthe treatment ofthe signs &symptoms ofDED(M, V, T, X)Improvementin visualacuity as earlyas day 56(Cequa)QID(Miebo)1-3% of pts.reportedblurred visionand eyeredness(Miebo)Lifitegrast5%(Xiidra)Improvementin SchirmerScore at day28(Tyrvaya)Wait 30minutes toinstill contactlenses(Miebo)Installationsitereactions 8%(Vevye)Fre99.8% ofpatientsreported no ormildstinging/burning(Vevye)e!Blurred Visionwas the mostcommon ocularadversereaction(Miebo)When TYRVAYAhas not beenused for morethan 5 days, re-prime with 1spray into the air65% of centralcorneas werecompletelyclear at 3months(Cequa)95% of patientsexperienced noor mildinstallation sitepain (Cequa)Availablefor $79(Vevye)The first andonly prescriptiondrop that directlytargets tearevaporation.05%Cyclosporine(Restasis).1%cyclosporine(Vevye)Relief frominflammationin the first 15days(Vevye)100%perfluorohexy-loctane(Miebo)Calcineurininhibitorimmuno-suppressantopthalmicsolution (Cequa)2ml in a5ml bottle(Vevye)Reduces thesigns of dry eyeby week 12 insome patients(Xiidra)

Competitive Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. 82% of patients reported sneezing (Tyrvaya)
  2. Ocular burning 17% (Restasis)
  3. 30 day supply is 60 .2ml vials (Xiidra)
  4. Improvement in corneal staining after just 14 days (Cequa)
  5. Money Back Guarantee (Vevye)
  6. Symptom Improvement in the first 30 days (Vevye)
  7. .03mg of varenicline (Tyrvaya)
  8. one month supply is 60 .25ml vials (Cequa)
  9. Symptomatic Relief in 2 weeks in 2 out of 4 studies (Xiidra)
  10. Throat irritation 13% of patients (Tyrvaya)
  11. .09% Cyclosporine (Cequa)
  12. Patients stay on treatment longer then Restasis and Xiidra (Cequa)
  13. Increase in Schirmer score of 10mm over vehicle in 6 mo (Restasis)
  14. 30-day supply is two 4.2ml bottles (Tyrvaya)
  15. Indicated for the treatment of the signs & symptoms of DED (M, V, T, X)
  16. Improvement in visual acuity as early as day 56 (Cequa)
  17. QID (Miebo)
  18. 1-3% of pts. reported blurred vision and eye redness (Miebo)
  19. Lifitegrast 5% (Xiidra)
  20. Improvement in Schirmer Score at day 28 (Tyrvaya)
  21. Wait 30 minutes to instill contact lenses (Miebo)
  22. Installation site reactions 8% (Vevye)
  23. Fre99.8% of patients reported no or mild stinging/burning (Vevye)e!
  24. Blurred Vision was the most common ocular adverse reaction (Miebo)
  25. When TYRVAYA has not been used for more than 5 days, re-prime with 1 spray into the air
  26. 65% of central corneas were completely clear at 3 months (Cequa)
  27. 95% of patients experienced no or mild installation site pain (Cequa)
  28. Available for $79 (Vevye)
  29. The first and only prescription drop that directly targets tear evaporation
  30. .05% Cyclosporine (Restasis)
  31. .1% cyclosporine (Vevye)
  32. Relief from inflammation in the first 15 days (Vevye)
  33. 100% perfluorohexy-loctane (Miebo)
  34. Calcineurin inhibitor immuno-suppressant opthalmic solution (Cequa)
  35. 2ml in a 5ml bottle (Vevye)
  36. Reduces the signs of dry eye by week 12 in some patients (Xiidra)